Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 131Squamous Cell Carcinoma of Head and Neck 75Lung Neoplasms 47Head and Neck Neoplasms 45Urinary Bladder Neoplasms 43Parkinson Disease 4, Autosomal Dominant Lewy Body 33Oropharyngeal Neoplasms 32Nasopharyngeal Carcinoma 31Biliary Tract Neoplasms 31Uterine Cervical Neoplasms 29Cholangiocarcinoma 28Esophageal Squamous Cell Carcinoma 24Neoplasms 23Carcinoma 23Neoplasm Metastasis 22Small Cell Lung Carcinoma 21Ovarian Neoplasms 21Carcinoma, Squamous Cell 20Stomach Neoplasms 18Colorectal Neoplasms 18Carcinoma, Transitional Cell 17Pancreatic Neoplasms 16Esophageal Neoplasms 16Mesothelioma, Malignant 15Gallbladder Neoplasms 15Mouth Neoplasms 14Laryngeal Neoplasms 13Hypopharyngeal Neoplasms 12Endometrial Neoplasms 11Triple Negative Breast Neoplasms 10

Interventions

Magnetic Resonance Spectroscopy 4Specimen Handling 3Radiotherapy, Intensity-Modulated 2Radiosurgery 2Indocyanine Green 2Conversion to Open Surgery 2Cisplatin 2Artificial Intelligence 2tislelizumab 1radium Ra 223 dichloride 1peposertib 1pembrolizumab 1lncRNA LNMAT1, human 1encorafenib 1cabozantinib 1binimetinib 1avelumab 1alovudine 1X-Rays 1Technetium-99 1Technetium 1Surgical Procedures, Operative 1Sentinel Lymph Node Biopsy 1Robotic Surgical Procedures 1Radiotherapy 1Radiation Dose Hypofractionation 1Propranolol 1Platinum Compounds 1Platinum 1Pemetrexed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphatic Metastasis × Cisplatin × 1 year × Clear all
NCT07353294 2026-04-22

Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 1 Enrolling by invitation
12 enrolled

Lymphatic Metastasis

NCT05075980 2026-04-13

Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

Mayo Clinic

Phase 2 Active not recruiting
174 enrolled
Head & Neck

Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Lymphatic Metastasis, Mouth Neoplasms, Oropharyngeal Neoplasms, Paranasal Sinus Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡